FDA OKs Second Gene Therapy for Hemophilia B

(MedPage Today) -- The FDA has approved a second gene therapy for adults with hemophilia B, drugmaker Pfizer announced on Friday.
The approval of fidanacogene elaparvovec (Beqvez) stipulates use in adult men with moderate to severe hemophilia...